NEW YORK, Nov. 13 – PerkinElmer has completed its acquisition of Packard BioScience, the company announced on Tuesday.

Packard will be integrated into PerkinElmer’s life-science unit, which will be led by John J. Engel, president of the division and executive vice resident of PerkinElmer, according to a statement.

Frank Witney, formerly president of Packard BioScience, has become president of drug discovery. He will report to Engel, PerkinElmer said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.